ArticleBioengineered2021

Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9.

Luo Qiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.